John Wood sees Government Defence and Green Energy Reviews as positive for InfraStrata #INFA Watch Now

Less Ads, More Data, More Tools Register for FREE
John Wood sees Government Defence and Green Energy Reviews as positive for InfraStrata #INFA
John Wood sees Government Defence and Green Energy Reviews as positive for InfraStrata #INFAView Video
Hardman & Co Mining Forum: Scotgold #SGZ prepare for production at Scottish gold/silver mine
Hardman & Co Mining Forum: Scotgold #SGZ prepare for production at Scottish gold/silver mineView Video

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.50
Bid: 16.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.25%)
Open: 16.50
High: 16.50
Low: 16.50
Yest. Close: 16.50
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
12th Dec 20177:00 amRNSCo-development agreement with Ergomed plc
7th Dec 20175:08 pmRNSHolding(s) in Company
22nd Nov 201711:36 amRNSResult of AGM
21st Nov 20177:00 amRNSBlock Listing Application
13th Nov 20177:00 amRNSAllergy Therapeutics to Present at Jefferies 2017
7th Nov 201712:59 pmRNSDirector/PDMR Shareholding
7th Nov 201711:54 amRNSDirector/PDMR Shareholding
19th Oct 20174:14 pmRNSPublication of Annual Report and notice of AGM
19th Oct 20177:00 amRNSCommencement of dosing in PQ Grass Phase II Trial
12th Oct 20175:39 pmRNSHolding(s) in Company
12th Oct 20172:55 pmRNSDirector/PDMR Shareholding
10th Oct 20177:15 amRNSHardman Research: Continuing to gain market share
28th Sep 20177:00 amRNSPreliminary Results
18th Sep 20177:00 amRNSApproval for PQ Grass Phase II trial
11th Sep 20177:00 amRNSExpansion of Clinical Development and R&D teams
15th Aug 20177:00 amRNSNotice of Results
18th Jul 20177:00 amRNSTrading Update
6th Jul 20177:00 amRNSPublication of adjuvant studies in journals
27th Jun 20177:00 amRNSInvestor and analyst site visits
19th Jun 20177:00 amRNSSatellite Symposium at EAACI 2017
6th Jun 20177:00 amRNSDirectorate changes
2nd Jun 201712:55 pmRNSHolding(s) in Company
13th Apr 20177:00 amRNSIssue of Equity
5th Apr 20177:15 amRNSHardman Research: Development across portfolio
29th Mar 20177:00 amRNSInterim Results for six months ended 31 Dec 2016
16th Mar 20177:00 amRNSFirst Patient in Pivotal Phase III Birch Study
9th Mar 20177:00 amRNSNotice of Interim Results
14th Feb 20177:00 amRNSHouse Dust Mite Allergy Vaccine Gains CTA Approval
8th Feb 20177:00 amRNSDirectorate Change
1st Feb 20177:00 amRNSPositive Efficacy & Safety Data in Peanut Vaccine
20th Jan 20177:15 amRNSHardman Research: Investment driving market share
19th Jan 20177:00 amRNSTrading Update
30th Dec 20162:31 pmRNSGrant of Awards
24th Nov 20165:23 pmRNSResult of AGM
2nd Nov 20167:00 amRNSEU Patent Office grants patent for MCT
27th Oct 20161:10 pmRNSIssue of equity in respect of exercise of options
24th Oct 20161:35 pmRNSAnnual Report and Accounts
10th Oct 20167:00 amRNSNew data from novel adjuvant system
3rd Oct 201611:28 amRNSIssue of equity in respect of exercise of options
29th Sep 201612:40 pmRNSDirector/PDMR Shareholding
28th Sep 20167:00 amRNSDirector/PDMR Shareholding
26th Sep 201611:59 amRNSDirector/PDMR Shareholding
26th Sep 201610:46 amRNSHardman Research: Performance drives market share
26th Sep 20167:00 amRNSAllergy Therapeutics Preliminary Results
20th Sep 20164:58 pmRNSIssue of equity in respect of exercise of options
5th Sep 20167:00 amRNSNotice of Preliminary Results
13th Jul 20167:00 amRNSTrading Update
8th Jul 20167:00 amRNSResults of mite immunotherapy Acarovac PlusT
27th Jun 20167:00 amRNSFindings from mEEC dose range finding study G204
13th Jun 20167:00 amRNSAllergy hosts Satellite Symposium at EAACI

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.